Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate Passes 'Right-to-Try' Measure Letting Terminally Ill Seek Investigational Drugs
Summary
The Senate approved a fifth substitute to HB94 on Feb. 13, allowing terminally ill patients access to investigational drugs and devices in U.S. trials under strict criteria, informed consent, and safeguards; vote recorded as 26–0 with absences.
The Senate passed a fifth substitute to HB94 on Feb. 13 to provide a legal pathway for terminally ill patients to access investigational drugs or devices that have completed phase I of FDA trials. Sponsor Sen. Vickers described the measure as carefully limited to items already in the FDA trial process and said it includes informed-consent and fraud-protection…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
